Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
KUAISHOU-W
01024
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -1.73%13.45B | -3.74%8.78B | -12.72%3.85B | -19.83%18.64B | -19.91%13.69B | -19.75%9.12B | -13.21%4.42B | -13.03%23.24B | 4.13%17.09B | 23.32%11.37B |
| Refunds of taxes and levies | -8.43%172.24M | -17.91%117.99M | -4.44%56.28M | -17.74%241.36M | -19.91%188.1M | -11.19%143.74M | -11.80%58.89M | 2.29%293.4M | -0.89%234.87M | 1.84%161.85M |
| Net deposit increase | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net increase in borrowings from central bank | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net increase in repurchase business capital | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Premiums received from original insurance contracts | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net cash received from reinsurance business | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net increase in deposits from policyholders | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net increase in funds disbursed | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net cash received from trading securities | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other operating activities | 13.72%183.92M | -24.75%89.99M | 64.60%53.14M | 13.52%306.99M | -23.59%161.73M | -9.41%119.6M | -57.30%32.28M | -24.34%270.43M | -47.92%211.65M | -48.65%132.02M |
| Cash inflows from operating activities | -1.65%13.81B | -4.22%8.99B | -12.05%3.96B | -19.42%19.18B | -19.96%14.04B | -19.52%9.39B | -13.83%4.51B | -13.02%23.81B | 2.82%17.54B | 21.05%11.66B |
| Goods services cash paid | 1.32%9.32B | -8.89%5.62B | -22.41%2.57B | -26.72%12.12B | -26.06%9.2B | -22.73%6.17B | -5.15%3.31B | -25.90%16.54B | -5.55%12.45B | 9.45%7.98B |
| Staff behalf paid | 0.80%1.72B | -6.55%1.13B | -2.82%578.2M | -3.38%2.39B | -4.15%1.71B | -0.84%1.21B | 2.90%595.01M | 29.91%2.48B | -3.70%1.78B | 3.88%1.22B |
| All taxes paid | 12.74%874.89M | 6.94%559.05M | 20.32%168.42M | -29.71%1.21B | -27.52%776M | -12.70%522.77M | -36.93%139.98M | 58.87%1.72B | 29.96%1.07B | 13.27%598.85M |
| Net loan and advance increase | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net deposit in central bank and institutions | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Net lend capital | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash paid for fees and commissions | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Policy dividend cash paid | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other operating activities | 11.09%911.3M | 31.78%750.28M | -35.07%60.23M | -0.93%1.27B | -14.59%820.34M | -7.15%569.32M | -51.99%92.75M | 41.23%1.28B | 54.79%960.47M | 42.87%613.19M |
| Cash outflows from operating activities | 2.59%12.83B | -4.85%8.06B | -18.43%3.37B | -22.82%16.99B | -23.07%12.51B | -18.67%8.47B | -7.70%4.14B | -16.02%22.02B | -1.29%16.26B | 10.49%10.42B |
| Net cash flows from operating activities | -36.35%972.69M | 1.54%927.9M | 59.07%590.07M | 22.42%2.19B | 19.68%1.53B | -26.63%913.79M | -50.47%370.96M | 55.14%1.79B | 119.05%1.28B | 502.33%1.25B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --0 | ---- | --0 | ---- | --0 | ---- | --0 | 311.30%63.24M | 387.98%67.89M | ---- |
| Cash received from returns on investments | -54.63%1.01M | -62.00%652.29K | -42.66%651.1K | -82.70%3.53M | -90.13%2.24M | -89.85%1.72M | -76.29%1.14M | 1,856.92%20.39M | 2,075.59%22.67M | 1,522.80%16.91M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 18.33%31.88M | 17.01%27.68M | -48.60%3.36M | -49.52%44.78M | -7.75%26.94M | 23.77%23.66M | -45.94%6.53M | -76.02%88.7M | -86.84%29.2M | -1.45%19.12M |
| Net cash received from disposal of subsidiaries and other business units | 15,793.32%476.8M | 15,793.32%476.8M | --477.6M | ---- | -99.56%3M | -99.42%3M | --0 | --790.01M | --686.9M | --518.34M |
| Cash received relating to other investing activities | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash inflows from investing activities | 1,484.13%509.69M | 1,680.16%505.14M | 6,183.94%481.61M | -94.98%48.31M | -96.01%32.17M | -94.88%28.38M | -62.91%7.66M | 149.08%962.34M | 240.64%806.65M | 1,513.82%554.36M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -11.66%288.5M | -14.26%211.41M | -7.75%71.55M | -18.94%420.78M | 6.47%326.57M | 9.98%246.58M | -15.32%77.56M | -3.46%519.11M | -40.18%306.71M | -35.48%224.21M |
| Cash paid to acquire investments | 360.80%23.04M | ---- | --0 | -88.89%5M | -77.78%5M | -77.78%5M | --0 | -52.84%45M | -53.26%22.5M | --22.5M |
| Net cash paid to acquire subsidiaries and other business units | --0 | ---- | --0 | 15.96%10.93M | --0 | ---- | --0 | --9.43M | --9.43M | --9.43M |
| Impawned loan net increase | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other investing activities | 30.57%7.09M | 68.43%6.98M | 429.24%4.93M | -73.73%10.89M | -89.32%5.43M | -83.27%4.14M | -80.99%931.4K | 116.46%41.46M | 526.12%50.86M | 1,108.68%24.78M |
| Cash outflows from investing activities | -5.45%318.63M | -14.60%218.39M | -2.57%76.47M | -27.22%447.61M | -13.48%337M | -8.97%255.73M | -36.28%78.49M | -5.72%615.01M | -31.55%389.5M | -19.64%280.92M |
| Net cash flows from investing activities | 162.68%191.06M | 226.13%286.75M | 672.02%405.13M | -214.96%-399.3M | -173.07%-304.83M | -183.14%-227.35M | 30.92%-70.82M | 230.59%347.33M | 225.57%417.15M | 186.75%273.44M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --0 | ---- | --0 | -66.03%2.71M | --2.71M | --2.71M | --0 | -92.01%7.99M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | ---- | --0 | -66.03%2.71M | --2.71M | --2.71M | --0 | -84.02%7.99M | ---- | ---- |
| Cash from borrowing | -95.50%28.04M | -98.64%7.85M | -97.12%7.35M | 34.29%653.66M | 56.57%622.7M | 81.41%578.68M | 28.00%255.63M | -65.68%486.75M | -65.98%397.7M | -63.96%318.99M |
| Cash received relating to other financing activities | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash inflows from financing activities | -95.52%28.04M | -98.65%7.85M | -97.12%7.35M | 32.67%656.37M | 57.26%625.41M | 82.26%581.4M | 28.00%255.63M | -67.42%494.74M | -68.66%397.7M | -67.62%318.99M |
| Borrowing repayment | -42.27%233.88M | -63.51%84.03M | -57.71%20.98M | 30.77%958.15M | -25.15%405.14M | -51.65%230.27M | -83.34%49.62M | -61.27%732.68M | -64.19%541.29M | -57.18%476.24M |
| Dividend interest payment | 1,165.99%551.95M | 3,539.43%545.75M | 29.20%7.9M | -12.85%574.07M | -93.16%43.6M | -39.36%15M | -34.69%6.11M | 29.53%658.68M | 29.73%637.74M | -37.36%24.73M |
| -Including:Cash payments for dividends or profit to minority shareholders | 28.14%21.19M | 1,780.83%15.85M | --5.68M | -18.57%17.54M | 159.79%16.54M | -85.64%842.52K | --0 | -64.02%21.53M | -88.84%6.37M | -68.63%5.87M |
| Cash payments relating to other financing activities | -95.85%46.56M | -96.98%33.48M | -43.32%10.83M | 1,386.44%1.15B | 2,289.02%1.12B | 4,273.15%1.11B | -5.15%19.1M | 7.43%77.69M | -27.25%46.96M | -50.42%25.32M |
| Cash outflows from financing activities | -47.00%832.4M | -50.97%663.27M | -46.94%39.71M | 82.91%2.69B | 28.11%1.57B | 157.02%1.35B | -77.14%74.84M | -40.58%1.47B | -40.71%1.23B | -56.25%526.29M |
| Net cash flows from financing activities | 14.90%-804.36M | 15.02%-655.41M | -117.90%-32.36M | -108.42%-2.03B | -14.11%-945.14M | -272.05%-771.26M | 241.57%180.79M | -2.12%-974.31M | -3.72%-828.28M | 4.79%-207.3M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -222.52%-35.69M | -120.86%-8.87M | -108.64%-3.29M | 47.28%70.71M | -124.56%-11.07M | -32.50%42.55M | 419.46%38.11M | -11.55%48.01M | 45.92%45.06M | 481.43%63.03M |
| Net increase in cash and cash equivalents | 21.13%323.69M | 1,401.68%550.36M | 84.87%959.55M | -113.85%-167.71M | -70.66%267.22M | -103.08%-42.28M | 2.42%519.03M | 10,290.29%1.21B | 276.19%910.84M | 535.93%1.37B |
| Add:Begin period cash and cash equivalents | -2.85%5.73B | -2.85%5.73B | -2.85%5.73B | 25.87%5.89B | 25.87%5.89B | 25.87%5.89B | 25.87%5.89B | -0.25%4.68B | -0.25%4.68B | -0.25%4.68B |
| End period cash equivalent | -1.81%6.05B | 7.26%6.28B | 4.25%6.69B | -2.85%5.73B | 10.15%6.16B | -3.40%5.85B | 23.58%6.41B | 25.87%5.89B | 33.89%5.59B | 38.32%6.06B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.